Your browser doesn't support javascript.
Psychotropic consumption before and during COVID-19 in Asturias, Spain.
García, María Luisa Nicieza; Martínez, Paula Fernández; Bretón, Eva Fernández; Martínez Alfonso, Marta M; Gil, Patricio Suárez.
  • García MLN; Health Department, General Directorate of Health Policy and Planning, Asturias, Spain. marisa.nicieza@gmail.com.
  • Martínez PF; Biostatistics and Epidemiology Platform, Health Research Institute of Asturias, Asturias, Spain. marisa.nicieza@gmail.com.
  • Bretón EF; Biostatistics and Epidemiology Platform, Health Research Institute of Asturias, Asturias, Spain.
  • Martínez Alfonso MM; Biostatistics and Epidemiology Platform, Health Research Institute of Asturias, Asturias, Spain.
  • Gil PS; Health Department, General Directorate of Health Policy and Planning, Asturias, Spain.
BMC Public Health ; 23(1): 494, 2023 03 15.
Artículo en Inglés | MEDLINE | ID: covidwho-2260102
ABSTRACT

BACKGROUND:

Spain as multiple other countries has been experiencing an increasing and sustained trend in the use of psychotropic medications since the mid 90s. Recent studies show public health measures implemented to control SARS-Cov2, such as mobility restrictions and the shutdown of nonessential activities increased mental suffering, even contributing to a higher number of anxiety, depression and insomnia disorders that could lead to an increase in the consumption of psychotropics. The aims were 1) Evaluate the temporal trend in psychotropic consumption by pharmacological subgroup, sex, and age group 2) Estimate the effect of the COVID-19 pandemic in the use of psychotropic drugs.

METHODS:

We conducted a retrospective observational study, retrieving all prescriptions of anxiolytics, hypnotics and sedatives, and antidepressants dispensed in pharmacies of Asturias (Northern Spain) for Primary Care patients for the period 2018-2021. We presented the data expressed in Daily Defined Doses (DDDs) for 1000 persons/day (DHD). To estimate changes in DHDs by year and age group we conducted two multiple linear regressions (one for males and one for females) for every pharmacological subgroup studied. Changes were considered statistically significant when the regression coefficient was p < 0.05. We used the Software R 4.1.0.

RESULTS:

For the studied period, the highest DHDs are for antidepressants, although all of the subgroups experienced an increase in consumption rates. Women consumed more psychotropic drugs than men. In 2021, 372 out of every 1000 women were taking daily 1 DDD of these drugs versus 184 out of every 1000 men. Consumption rates for all psychotropic drugs progressively increases with age. Conversely, the biggest increases in consumption were among the youngest age groups (0-14 and 15-29 years) for women, while for men there is more variability. The regression models suggest an upward trend in psychotropic consumption during all the period, especially remarkable from 2020, for both genders and all age groups.

CONCLUSIONS:

- The consumption of psychotropic drugs has gradually increased over the last 4 years, with a significant boost starting in 2020 for both sexes, matching the start of the SARS-COV2 pandemic and the implementation of strict Public Health measures to contain it. - The increase observed on children and adolescents is a matter of concern.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adolescente / Niño / Femenino / Humanos / Masculino País/Región como asunto: Europa Idioma: Inglés Revista: BMC Public Health Asunto de la revista: Salud Pública Año: 2023 Tipo del documento: Artículo País de afiliación: S12889-023-15360-0

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adolescente / Niño / Femenino / Humanos / Masculino País/Región como asunto: Europa Idioma: Inglés Revista: BMC Public Health Asunto de la revista: Salud Pública Año: 2023 Tipo del documento: Artículo País de afiliación: S12889-023-15360-0